论文部分内容阅读
目的观察皮内针疗法防治肝细胞癌患者经导管肝动脉化疗栓塞(TACE)术后疼痛的临床疗效。方法将70例首次行TACE术的中、晚期肝细胞癌患者随机分为皮内针组和假皮内针组各35例。在TACE术前3 h,皮内针组采用皮内针疗法,取右侧肝俞穴皮下埋针,假皮内针组将皮内针针柄贴于右侧肝俞穴,两组均埋针24 h。采用语言描述评分法(VRS)在TACE术后1、3、6、24 h对两组患者进行疼痛分级评价,并观察术后24 h内两组患者使用盐酸羟考酮缓释片例数。结果在TACE术后1、3、6、24 h时,VRS疼痛分级结果显示皮内针组在0级和Ⅰ级的例数多于假皮内针组,而Ⅱ、Ⅲ级例数少于假皮内针组,差异具有统计学意义(P<0.05);在TACE术后24 h内,皮内针组使用盐酸羟考酮缓释片患者11例,显著少于假皮内针组的23例(P<0.05)。结论皮内针疗法能够有效防治TACE术后患者在24 h内的疼痛症状,减少服用盐酸羟考酮缓释片情况。
Objective To observe the clinical efficacy of intradermal acupuncture in preventing postoperative pain of transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma. Methods Seventy patients with primary hepatocellular carcinoma who underwent TACE for the first time were randomly divided into intradermal injection group and intradermic injection of 35 patients. At 3 h before TACE, the intradermal needle was treated with intradermal acupuncture and the subcutaneous embedding needle was placed in the right liver shu point. The intradermal acupuncture needle stick was affixed to the right liver shu point, and both groups were buried Needle 24 h. Pain scores were evaluated by language description score (VRS) at 1, 3, 6 and 24 h after TACE, and the number of oxycodone hydrochloride sustained-release tablets in both groups was observed within 24 hours after operation. Results At 1, 3, 6 and 24 hours after TACE, the grading results of VRS showed that the number of grade 0 and grade Ⅰ in the intradermal needle group was more than that of the sham group, while the number of grade Ⅱ and Ⅲ was less than (P <0.05). Within 24 hours after TACE, 11 patients in the intradermal needle group were treated with oxycodone hydrochloride sustained-release tablets, which were significantly lower than those in the sham-treated group 23 cases (P <0.05). Conclusion Intradermal acupuncture can effectively prevent and treat the pain symptoms in 24 h after TACE and reduce the incidence of oxycodone hydrochloride sustained-release tablets.